Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print True cancer-causing genes revealed by new technique, say Stanford researchers
Slashdot It! Slashdot True cancer-causing genes revealed by new technique, say Stanford researchers
Submit to Reddit Submit True cancer-causing genes revealed by new technique, say Stanford researchers to Reddit
Reading: True cancer-causing genes revealed by new technique, say Stanford researchersTwitter This Reading: True cancer-causing genes revealed by new technique, say Stanford researchersTwitter True cancer-causing genes revealed by new technique, say Stanford researchers
Add to Facebook Add True cancer-causing genes revealed by new technique, say Stanford researchers to Facebook

True cancer-causing genes revealed by new technique, say Stanford researchers

June 13, 2005

STANFORD, Calif.-Often cancer research goes like this: study cancerous cells in a lab dish, find mutations that appear in many of the samples, develop drugs to target proteins made by the mutated genes, and voila, new chemotherapy drugs are born. Or at least that's the hope.

The problem with this approach is that while some mutations do lead to cancer, others just tag along, frequently occurring but not driving the cancer to spread. New research under the direction of Paul Khavari, MD, PhD, professor in the Program in Epithelial Biology at the Stanford University School of Medicine and chief of the dermatology service at the Veterans Affairs Palo Alto Healthcare System, shows a novel and more effective way of testing which mutations cause cancer and which are mere research distractions. The work is published in the June issue of Nature Genetics.




"If you have multiple suspects at the scene of a crime, you don't know who committed the offense," said Khavari. Without any way of differentiating the criminal from the bystander, researchers and drug companies spend time and money investigating all suspects. But Khavari and his colleagues have developed a technique that allows scientists to distinguish more quickly between possible perpetrators: they grew human skin cells on the skin of mice where the researchers could see the effects of mutations they induced.

"The surprise in this study was that what is perhaps the most famous mutation in this cancer didn't cause melanoma," Khavari said. A mutation in a gene for the protein B-Raf shows up in the majority of all melanoma cases. "This suggests that it must be doing something," Khavari said. But when co-first authors graduate student Yakov Chudnovsky and postdoctoral scholar Amy Adams, MD, PhD, made that mutation in their melanoma model, the cells did not become cancerous.

Although these results came as a surprise, several cancer trials under way to target the B-Raf protein with chemotherapy haven't been successful in treating melanoma. If people developing chemotherapy drugs had access to Khavari's mouse model, they might have suspected that their trials would be in vain.

B-Raf turned out to be incapable of creating cancer, but another commonly mutated gene appeared to be a true criminal. Mutations in the gene that makes a protein called PI3K do cause melanoma in the mouse model.

"These studies highlight which mutations are primary drivers of cancer and allow us to focus in on that pathway," Chudnovsky said.

This work could be a breakthrough for studying one of the hardest cancers to treat. Melanoma first appears as a mole or skin discoloration. The best way to beat the disease is to remove this early cancer before it spreads. "Once it spreads, there are no therapies that are universally effective," Khavari said.

The key to this study was developing a way to induce mutations in the human skin cells and transplant them onto the mice. In the past, researchers studied melanoma in a lab dish where the cells don't behave like normal cancers. And although mice can develop melanoma, it is quite different than the human disease and is also not an ideal way of studying human cancer.

Chudnovsky said that tricking the human cells to grow on mice was no small feat. "Normally the changes leading to cancer take 60 or so years to develop. We telescoped that process into a matter of days," he said. This allowed Chudnovsky and Adams to test several different criminal suspects for their ability to cause cancer.

In future work the team hopes to test additional mutations and develop similar models for other forms of human cancers.

Stanford University Medical Center





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Cancer Cells   Nanospheres   Quantum Dots   Biofuel   Cocaine   Brain Activity   Hemophilia   Myopia   Photosynthesis   Oxidative Stress   Immunization   Antipsychotic   Hydrogen Storage   Embryonic Development   Second-hand Smoke   Newborn Screening   Neuroticism   Bird Species   Cancer Treatment   Tobacco   Cocaine Addiction   Fusion   Folic Acid   Myocardial Infarction   Cosmic Radiation  
Related Chemotherapy Drugs Current Events and Chemotherapy Drugs News Articles Chemotherapy Drugs Current Events and Chemotherapy Drugs News RSS Chemotherapy Drugs Current Events and Chemotherapy Drugs News RSS
Like burrs on your clothes, molecule-size capsules can deliver drugs by sticking to targeted cells
It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials with almost 100 percent efficiency to targeted cells in the bloodstream.

Caucasians are at higher risk of developing Ewing's sarcoma than other races
The largest analysis of its kind has found that Caucasians are much more likely than people in other racial/ethnic groups to develop a rare bone and soft tissue cancer called Ewing's sarcoma.

Potential for noninvasive brain tumor treatment
Duke University engineers have taken a first step toward a minimally invasive treatment of brain tumors by combining chemotherapy with heat administered from the end of a catheter.

Link unraveled between chromosomal instability and centrosome defects in cancer cells
In a new study, Dana-Farber Cancer Institute scientists disprove a century-old theory about why cancer cells often have too many or too few chromosomes, and show that the actual reason may hold the key to a novel approach to cancer therapy.

I-SPY trial offers key insights into locally advanced breast cancer
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease.

Less-toxic drug prolongs survival in metastatic breast cancer
Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug.

New Tool for Next-Generation Cancer Treatments using Nanodiamonds
A research team at Northwestern University has demonstrated a tool that can precisely deliver tiny doses of drug-carrying nanomaterials to individual cells.

Two targeted therapies likely better than one in patients with aggressive lymphoma
When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG).

Triple drug combination is promising option to treat metastatic HER2+ breast cancer
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.

Study shows chemotherapy improves survival among older breast cancer patients
The average age of a woman diagnosed with breast cancer is 63, so it is critical to have effective proven, therapies for an older patient population.
More Chemotherapy Drugs Current Events and Chemotherapy Drugs News Articles
Physicians' Cancer Chemotherapy Drug Manual: 2009

Physicians' Cancer Chemotherapy Drug Manual: 2009
by Edward Chu (Author), Vincent DeVita Jr. (Author)

Completely revised and updated for 2009, the Physicians Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in the clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens both on-and off-label for the treatment of all the major cancers. Special features: Features new drugs: Bendamustine, Ixabepilone, and Nilotinib; Revised to reflect rapid advances in the field, incorporating new drug and treatment strategies; diagrams of drug structures and pathways for each agent; Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages; Covers...

Chemotherapy - Questions and Answers about Chemotherapy and Cancer Treatments.  Everything You Need to Know about Chemotherapy

Chemotherapy - Questions and Answers about Chemotherapy and Cancer Treatments. Everything You Need to Know about Chemotherapy

About This Book

Chemotherapy and You is written for you - someone who is about to receive or is now receiving chemotherapy for cancer. Your family, friends, and others close to you may also want to read this book.

This book is a guide you can refer to throughout your chemotherapy treatment. It includes facts about chemotherapy and its side effects and also highlights ways you can care for yourself before, during, and after treatment.
Rather than read this book from beginning to end, look at just those sections you need now. Later, you can always read more.

This book covers:

* Questions and answers about chemotherapy. Answers common questions, such as what chemotherapy is and how it affects cancer cells.
* Side effects and ways to manage them....

Psi Bands, Drug-Free Wrist Bands for the Relief of Nausea - Daisy Chain

Psi Bands, Drug-Free Wrist Bands for the Relief of Nausea - Daisy Chain
by Psi Health Solutions, Inc.

Psi Bands (pronounced "Sigh Bands") are drug-free wrist bands for the relief of nausea due to morning sickness (pregnancy), motion sickness/travel, chemotherapy, and anesthesia. Psi Bands fit wrists measuring 5 ¼ inches up to 8 ¼ inches in diameter. Wear two at a time (2 come per package). Breathe a "Psi" of relief. For a limited time, $1 of every Cherry Blossom Psi Bands sold will be donated to Fertile Hope. Fertile Hope provides reproductive information to cancer patients whose medical treatments present the risk of infertility.

BMV Quantum Subliminal CD Chemotherapy Aid (Ultrasonic Peak Health Series)

BMV Quantum Subliminal CD Chemotherapy Aid (Ultrasonic Peak Health Series)

Program your subconscious mind to maximize your health, improve self-healing during the chemotherapy process and reduce negative symptoms and negative side-effects related to chemo treatment. Using exclusive state-of-the-art subliminal and brainwave entrainment technologies, you can program your subconscious mind for positive lasting results, created by a Certified Hypnotherapist and NLP Practitioner (Neuro-Linguistic Programming). Silent affirmations, inaudible hypnotic suggestions and thousands of powerful subliminal messages program your subconscious mind for positive results. The first 3 tracks have an ocean background. The Silent Ultrasonic Track 4 is completely silent with no sound at all! BMV exclusive Quantum Subliminal Matrix Technology sets a new standard for the subliminal...

Cancer Chemotherapy Pocket Guide (Periodicals)

Cancer Chemotherapy Pocket Guide (Periodicals)
by Carol S., R. N. Viele (Author), Lloyd E., M.D. Damon (Author), Alan, M.D. Venook (Author), Robert J. Ignoffo (Editor)

This handbook is a convenient quick reference for physicians, nurses, and pharmacists involved in the pharmacologic management of cancer patients. It provides concise and rapidly accessible information on available anticancer drugs, chemotherapy protocols, and guidelines for the use of ancillary drugs such as antiemetics, hematopoietic growth factors, and hypocalcemic agents. Information is presented in an easy-to-scan outline format, with numerous tables, charts, and icons indicating potential adverse reactions patients may experience from exposure to the chemotherapeutic agents presented in Chapter 1.Major sections of the book describe current anticancer drugs and present evidence-based chemotherapy regimens for specific cancers in adults and pediatric patients....

Physician's Cancer Chemotherapy Drug Manual 2008 (Jones and Bartlett Series in Oncology)

Physician's Cancer Chemotherapy Drug Manual 2008 (Jones and Bartlett Series in Oncology)
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)

Completely revised and updated for 2008, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalogue of over 100 drugs-both on- and off-label-commonly used in cancer treatment. A section on Common Chemotherapy Regimens provides a quick reference to management of specific cancers, arranged alphabetically.

  Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)
by Humana Press

Univ. of Manchester, UK. Focuses on the key issues in apoptosis as they affect cancer pathology and chemotherapy. Presents potential targets for tumor therapy and control points for cancer, viral infection, neurodegenerative disorders, and stroke. For researchers and practitioners. DNLM: Neoplasms--drug therapy.

Physicians' Cancer Chemotherapy Drug Manual, 2007

Physicians' Cancer Chemotherapy Drug Manual, 2007
by Edward; M.D. Chu (Author)

Completely revised and updated for 2007, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalogue of over 100 drugs-both on- and off-label-commonly used in cancer treatment, including several new agents (recently or about to be FDA approved). A section on Common Chemotherapy Regimens provides a quick reference to management of specific cancers, arranged alphabetically. A comprehensively revised introductory chapter on Principles of Chemotherapy offers a concise, current overview of the field. Special features include: Special chapter profiling anti-emetic drugs Diagrams of drug structures and pathways Complete discussion of clinical pharmacology, indications, and dosages Coverage of toxicity and...

Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches, and Development

Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches, and Development
by Informa HealthCare

This invaluable reference presents a comprehensive review of the basic methods for characterizing bioadhesive materials and improving vehicle targeting and uptake-offering possibilities for reformulating existing compounds to create new pharmaceuticals at lower development costs. Evaluates the unique carrier characteristics of bioadhesive polymers and their power to enhance localization of delivered agents, local bioavailability, and drug absorption and transport! Written by over 50 international experts and reflecting broad knowledge of both traditional bioadhesive strategies and novel clinical applications, Bioadhesive Drug Delivery Systems · discusses mechanical and chemical bonding, polymer-mucus interactions, the effect of surface energy in bioadhesion, polymer hydration, and...

PDR Nurse's Drug Handbook, 2009

PDR Nurse's Drug Handbook, 2009
by Physicians' Desk Reference (Author), Ivy M. Alexander (Foreword)

Combines effectiveness and efficiency to maintain superior patient care

Aiming to prevent medication errors and clinical accountability like no other drug resource, the 2009 PDR Nurse's Drug Handbook places up-to-the-minute, FDA-approved prescribing information at the reader's fingertips. With two drug indices, one organized by brand/generic name and the other by therapeutic class, the 2009 PDR Nurse's Drug Handbook offers over 1,100 concise drug monographs, a detailed pill image section containing nearly 300 photographs, valuable appendices containing nearly 100 quick reference charts & tables and nursing considerations for every drug monograph. With its new single-column format to allow for quick point-of-care referencing, the 2009 PDR Nurses Drug Handbook is the essential drug...

© 2009 BrightSurf.com